4 completed, 2 terminated. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Terminated 2 |
Follow Back Pain Lower Back Chronic: new trials by email Literature Review of Back Pain Lower Back Chronic trials Research Report on Back Pain Lower Back Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Melatonin fOr CHronic bAck Pain (The MOCHA Trial) Melatonin 10 MG, Placebo - Back Pain Lower Back Chronic, Insomnia | Phase 3 | Completed | Odense University Hospital | 220 | 2024-12-11 | 2026-04-22 |
| An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain Duloxetine - Back Pain Lower Back Chronic | Phase 3 | Completed | Eli Lilly and Company | 151 | 2013-09-01 | 2016-01-27 |
| A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain Duloxetine, Placebo - Back Pain Lower Back Chronic | Phase 3 | Completed | Eli Lilly and Company | 458 | 2013-05-01 | 2015-07-23 |
| Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain Placebo, Hydrocodone bitartrate - Back Pain Lower Back Chronic | Phase 3 | Completed | Zogenix, Inc. | 510 | 2010-03-01 | 2022-12-08 |
| Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015 Buprenorphine transdermal patch - Back Pain Lower Back Chronic | Phase 3 | Terminated | Purdue Pharma LP | 354 | 2004-06-01 | 2012-09-03 |
| Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain Buprenorphine, Oxycodone Immediate-Release - Back Pain Lower Back Chronic | Phase 3 | Terminated | Purdue Pharma LP | 660 | 2004-02-01 | 2012-09-03 |
Low Back Pain (2) · Back Pain (1) · Chronic Pain (1) · Sleep Initiation and Maintenance Disorders (1)
Neurologic Manifestations (3) · Pain (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Back Pain (2) · Dyssomnias (1) · Mental Disorders (1) · Nervous System Diseases (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1)
Buprenorphine (2) · Duloxetine Hydrochloride (2) · Hydrocodone (1) · Melatonin (1) · Sugars (1)
Eli Lilly and Company (2) · Purdue Pharma LP (2) · Odense University Hospital (1) · Zogenix, Inc. (1)
United States (3) · Japan (2) · Denmark (1)
Deborah L Steiner, MD, MS (1) · Karin Due Bruun, PhD (1) · Kevin Romanko, DPM (1) · Martin Hale, MD (1)
PMID 21807566, PMID 28919811, PMID 31875196, PMID 41250112
2023 (1)